骨髓干细胞的可塑性及其在栓塞性疾病中的应用

栓塞性血管阻塞在急性心肌梗死、脑梗塞、血栓闭塞性脉管炎、糖尿病足等发病过程中起着重要作用。目前临床上针对这些疾病的治疗手段主要有：药物溶栓、血管旁路移植和介入手术等,多年来其治疗方法无实质性进展。上个世纪九十年代人们发现了干细胞新的生物学特性—可塑性,对干细胞可塑性的研究以及相关技术的发展为心脏病、老年痴呆、帕金森等的治疗带来了希望,也为栓塞性疾病的治疗开辟了新途径,有望成为治疗手段之一。     

完全体外化牛细胞核移植的研究

本研究探讨了用体外成熟卵母细胞和体外受精胚胎进行核移植的可能性。本研究结果在我国首次获得牛核移植的成功。从屠宰场回收的卵巢中抽取卵球－卵母细胞复合体，采用以前报道的方法（石德顺等，广西农业大学学报’１９９４：１３：１－５）进行体外成熟（ＩＶＭ）和体外受精（ＩＶＦ），获得ＩＶＭ卵母细胞和ＩＶＦ胚胎，体外成熟２３－２４ｈ后，在含０．１％透明质酸酶的无钙镁ＰＢＳ（ＰＢＳ）内，用细管反复吹打去掉卵丘细胞。选择具有明显第一极体的卵母细胞通过显微操作移去第一极体及其附近约一半的细胞质进行去核，去核的卵细胞在成熟液内继续培养到ＩＶＭ３０ｈ．体外发育到８－３２细胞期的ＩＶＦ胚胎用作核供体．供体胚胎用含０．２５％Ｐｒｏｎａｓｅ（溶于ＰＢＳ￣－）溶解透明带，并用细管吹打将其分散成单个卵裂球，在ＩＶＭ３０ｈ将单个卵裂球显微注入去核卵母细胞的卵周隙内，并在ＩＶＭ３１ｈ用８０Ｖ／ｍｍ４０μｓ两次电脉冲（间隔１秒）来诱导卵裂球与去核卵母细胞的融合。融合卵在颗粒细胞单层培养滴内共培养，体外培养２４ｈ后观察卵裂结果，经体外培养５－８天后发育到桑椹和囊胚的核移植胚胎移植到同期发情的受体．２个月后直检妊娠情况．本实验中共操作１９４枚卵母细胞，     

Purification of platelet-derived endothelial cell growth inhibitor and its characterization as transforming growth factor-β type 1

In 1986, Brown and Clemmons (Proc. natl Acad. Sci. USA83 (1986) 3321) showed that platelets contain a substance, platelet-derived growth inhibitor (PDGI), that inhibits in vitro endothelial cell replication. Although platelets are rich in transforming grwoth factor (TGF-), PDGI was considered not to be related to TGF-, on the basis of its reported properties (extraction from platelets at neutral pH, binding to heparin-Sepharose). However, we purified PDGI to near homogeneity and showed that on the basis of HPLC retention behavior, in vitro growth inhibitory activities with several cell types, receptor binding, and immunoneutralization of growth inhibitory activity with specific anti-TGF- type 1 antibodies, PDGI is most probably identical with TGF- type 1.     

In vitro amiodarone protein binding and its interaction with warfarin

Summary The binding of amiodarone to human plasma protein and to bovine serum, albumin was studied by three different methods, ultracentrifugation, equilibrium dialysis and fluorescence spectroscopy. The fraction of amiodarone bound to plasma protein amounted to 96.3%. The changes in the binding properties of 1-anilino-naphthalene-8-sulfonate for bovine serum albumin using warfarin and amiodarone as independent inhibitors were analyzed in terms of binding site specificity. The findings indicated that amiodarone and warfarin have two different binding sites on bovine serum albumin, so a noncompetitive inhibition mechanism was indicated. On the basis of our data we cannot exclude other mechanisms of interaction besides direct displacement of one drug by another; nevertheless, metabolite interference between amiodarone and coagulation cofactors may better explain the enhancement of warfarin's pharmacological action in association with amiodarone.This work was partially funded by the CNR (National Research Council, Rome, Italy), Program on Clinical Pharmacology and Rare Diseases. The authors would like to thanks Drs E. Marzi and E. riva for their help.     

Thrombospondin co-localises with TGFβ and IGF-I in the extracellular matrix of human osteoblast-like cells and is modulated by 17β estradiol

Thrombospondin (TSP) is a multifunctional glycoprotein which is synthesised by several cell types including osteoblasts, and incorporated into the extracellular matrix (ECM) of these cells. The function and regulation of TSP in bone is not clear. In this study, using a long term culture model of human osteoblast-like cells, we examined the distribution of TSP in the ECM and its modulation by added estradiol. In this model the osteoblast-like cells form a regular multilayer which continues to increase in depth up to 50 days post confluence. In the ECM of these cultures and in 19-week fetal bone, the bone markers osteocalcin and alkaline phosphatase were diffusely distributed in the matrix. In contrast, labelling for TSP was concentrated, confined to the banded collagen and its immediately adjacent ECM. This pattern of labelling resembled that of the growth factors transforming growth factor-I (TGF), and insulin-like growth factor-I (IGF-I), with which TSP label co-localised. Labelling intensities were comparable between fetal bone and the in vitro material for TSP, TGF and IGF-I. TSP label was present by 10 days post confluence, reached a maximum by 20 days, and declined slowly thereafter, a time course which was similar to that of IGF-I. Incubation of osteoblast-like cell cultures with 17 estradiol resulted in an increase in multilayer depth and a maximal 3-fold increase in TSP labeling at 30 days as well as approximately 2-fold increases for TGF and IGF-I. The dose-response relationship for these responses to estradiol treatment was biphasic with maximal increases at 10^–10 M–10^–11 M of added estradiol. Treatment with 17 estradiol produced labelling intensities that were not significantly different from controls. Studies with other cell types have suggested that TSP may be involved in modulation of growth factor activity. The similarities between TSP, TGF and IGF-I, in terms of their distribution and regulation by 17 estradiol treatment, may indicate a role for TSP in modulating bone cell proliferation and function through interaction with local growth factors.     

不同贮藏条件下鳗骨油氧化特性的研究

研究了室温下（15℃）鳗骨油在空气中的自氧化速度,以及温度和贮藏条件对鳗骨油氧化速度的影响。实验所设的温度梯度分别为6℃、15℃、35℃,贮藏条件分别是敞口,密封（蜡封）和用N2驱除氧气后密封保存。实验结果显示,室温下鳗骨油在空气中的自氧化速度,敞口存放4天,过氧化值就已超过0.15;温度和贮藏条件对鳗骨油的氧化速度有显著影响,驱除氧气低温贮藏可以有效地防止鳗骨油的氧化。     

骨髓干细胞与急性心肌梗死的血管新生

骨髓干细胞可分化为心肌细胞、血管内皮细胞、平滑肌细胞等，能再生心肌和血管，可用于心肌梗死的治疗。本文就骨髓干细胞在血管新生方面的生物学特性及其对心梗后的血管新生作用作一综述。     

无关供者骨髓移植治疗多次复发性急性白血病

文章探讨无关供者骨髓移植治疗多次复发急性白血病的疗效 .经改良 Bucy方案预处理后对一例第三次复发的急粒患者行无关供者骨髓移植 ,同时给防治 GVHD、抗感染治疗 .结果 + 2 1天骨髓在患者体内植活 ,+ 35天细胞染色体分析呈供者型 ( 4 6,XX.正常核型 ) ,+ 84天血型转换成供者型 ,至今已无病生存超过 6个月 .结果表明 ,无关供者骨髓移植对多次复发的急性白血病患者具有治疗价值     

猪骨形态发生蛋白体外诱导小鼠肌组织成骨的实验研究

这项研究借助体外培养技术，动态观察猪骨形态发生蛋白对小鼠骨骼肌增殖分化的作用。实验结果表明，猪骨形态发生蛋白可体外诱导新生鼠骨骼成骨，但对成年鼠骨骼肌无诱导作用；ＲＰＭＩ－１６４０培养基可使软骨细胞表型得以充分表达；建立的实验模型对鉴定骨形态发生蛋白活性有一定实用价值。此外，在体外诱导肌组织成骨实验过程中还观察到其它学者未曾报道过的软骨溶解期。     

多功能单侧外固定支架治疗胫骨开放性骨折21例

采用ＳＧＤ骨科多功能单侧外固定支架治疗严重胫骨开放性骨折２１例，取得满意疗效。该多功能单侧外固定支架能方便准确地对骨折端进行复位和固定，对骨折端具有加压作用，固定牢靠；穿针部位避开骨折处，且穿针数目少，术中软组织损伤少；术后调整容易，不影响非固定部位的关节活动。